These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25270953)

  • 1. Cancer: Lipid kinase PIP5K1α as a new target in prostate cancer.
    Flemming A
    Nat Rev Drug Discov; 2014 Oct; 13(10):723. PubMed ID: 25270953
    [No Abstract]   [Full Text] [Related]  

  • 2. PIP5K1α inhibition as a therapeutic strategy for prostate cancer.
    Drake JM; Huang J
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12578-9. PubMed ID: 25118275
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer.
    Semenas J; Hedblom A; Miftakhova RR; Sarwar M; Larsson R; Shcherbina L; Johansson ME; Härkönen P; Sterner O; Persson JL
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):E3689-98. PubMed ID: 25071204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor.
    Sarwar M; Syed Khaja AS; Aleskandarany M; Karlsson R; Althobiti M; Ødum N; Mongan NP; Dizeyi N; Johnson H; Green AR; Ellis IO; Rakha EA; Persson JL
    Oncogene; 2019 Jan; 38(3):375-389. PubMed ID: 30104711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer.
    Larsson P; Syed Khaja AS; Semenas J; Wang T; Sarwar M; Dizeyi N; Simoulis A; Hedblom A; Wai SN; Ødum N; Persson JL
    Int J Cancer; 2020 Mar; 146(6):1686-1699. PubMed ID: 31381135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an in vitro screening assay for PIP5K1α lipid kinase and identification of potent inhibitors.
    Strätker K; Haidar S; Amesty Á; El-Awaad E; Götz C; Estévez-Braun A; Jose J
    FEBS J; 2020 Jul; 287(14):3042-3064. PubMed ID: 31876381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual blockade of the lipid kinase PIP4Ks and mitotic pathways leads to cancer-selective lethality.
    Kitagawa M; Liao PJ; Lee KH; Wong J; Shang SC; Minami N; Sampetrean O; Saya H; Lingyun D; Prabhu N; Diam GK; Sobota R; Larsson A; Nordlund P; McCormick F; Ghosh S; Epstein DM; Dymock BW; Lee SH
    Nat Commun; 2017 Dec; 8(1):2200. PubMed ID: 29259156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydroisoquinoline-Derived Urea and 2,5-Diketopiperazine Derivatives as Selective Antagonists of the Transient Receptor Potential Melastatin 8 (TRPM8) Channel Receptor and Antiprostate Cancer Agents.
    De Petrocellis L; Arroyo FJ; Orlando P; Schiano Moriello A; Vitale RM; Amodeo P; Sánchez A; Roncero C; Bianchini G; Martín MA; López-Alvarado P; Menéndez JC
    J Med Chem; 2016 Jun; 59(12):5661-83. PubMed ID: 27232526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of BCRP-mediated drug efflux by fumitremorgin-type indolyl diketopiperazines.
    van Loevezijn A; Allen JD; Schinkel AH; Koomen GJ
    Bioorg Med Chem Lett; 2001 Jan; 11(1):29-32. PubMed ID: 11140726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of RAD001 (everolimus) and docetaxel reduces prostate and breast cancer cell VEGF production and tumour vascularisation independently of sphingosine-kinase-1.
    Alshaker H; Wang Q; Böhler T; Mills R; Winkler M; Arafat T; Kawano Y; Pchejetski D
    Sci Rep; 2017 Jun; 7(1):3493. PubMed ID: 28615679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
    Pchejetski D; Bohler T; Brizuela L; Sauer L; Doumerc N; Golzio M; Salunkhe V; Teissié J; Malavaud B; Waxman J; Cuvillier O
    Cancer Res; 2010 Nov; 70(21):8651-61. PubMed ID: 20959468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential actions on voluntary alcohol intake of tetrahydroisoquinolines or a beta-carboline infused chronically in the ventricle of the rat.
    Myers RD; Melchior CL
    Pharmacol Biochem Behav; 1977 Oct; 7(4):381-92. PubMed ID: 563084
    [No Abstract]   [Full Text] [Related]  

  • 13. The sphingosine kinase inhibitor 2-(p-hyroxyanilino)-4-(p-chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress-dependent mechanism.
    Tonelli F; Alossaimi M; Williamson L; Tate RJ; Watson DG; Chan E; Bittman R; Pyne NJ; Pyne S
    Br J Pharmacol; 2013 Mar; 168(6):1497-505. PubMed ID: 23113536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biogenic amine-aldehyde condensation products: tetrahydroisoquinolines and tryptolines (beta-carbolines).
    Deitrich R; Erwin V
    Annu Rev Pharmacol Toxicol; 1980; 20():55-80. PubMed ID: 6992705
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition kinetics and regulation of sphingosine kinase 1 expression in prostate cancer cells: functional differences between sphingosine kinase 1a and 1b.
    Lim KG; Tonelli F; Berdyshev E; Gorshkova I; Leclercq T; Pitson SM; Bittman R; Pyne S; Pyne NJ
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1457-64. PubMed ID: 22634604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,5-diketopiperazines from the marine-derived fungus Aspergillus fumigatus YK-7.
    Wang Y; Li ZL; Bai J; Zhang LM; Wu X; Zhang L; Pei YH; Jing YK; Hua HM
    Chem Biodivers; 2012 Feb; 9(2):385-93. PubMed ID: 22344914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer.
    Pchejetski D; Böhler T; Stebbing J; Waxman J
    Nat Rev Urol; 2011 Sep; 8(10):569-678. PubMed ID: 21912422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol drinking in the rat induced by acute intra-cerebral infusion of two tetrahydroisoquinolines and a beta-carboline.
    Myers RD; Oblinger MM
    Drug Alcohol Depend; 1977; 2(5-6):469-83. PubMed ID: 562253
    [No Abstract]   [Full Text] [Related]  

  • 19. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models.
    Pchejetski D; Golzio M; Bonhoure E; Calvet C; Doumerc N; Garcia V; Mazerolles C; Rischmann P; Teissié J; Malavaud B; Cuvillier O
    Cancer Res; 2005 Dec; 65(24):11667-75. PubMed ID: 16357178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting sphingosine kinase 1 in cancer.
    Pyne NJ; Tonelli F; Lim KG; Long J; Edwards J; Pyne S
    Adv Biol Regul; 2012 Jan; 52(1):31-8. PubMed ID: 21791223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.